Skip to main content
SpringerLink
Log in

Drug approval in EU should require agreement on fair price

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Mahase E. EU drug approval should include price evaluation, says expert panel. BMJ 2019: l6591, No. 367, 19 Nov 2019. Available from: URL: https://doi.org/10.1136/bmj.l6591

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Drug approval in EU should require agreement on fair price. PharmacoEcon Outcomes News 842, 33 (2019). https://doi.org/10.1007/s40274-019-6425-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6425-1

Search

Navigation